| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Biowatch Alert: Provectus Jumps 15% On 6x Volume
Posted on 04/24/2007 11:35:57 | Link | Post Comment
by H.S. Ayoub
BioHealthInvestor.com
Shares of Provectus Pharmaceuticals (PVCT.OB) gained more than 15% on Monday as volume was more than six times the 3 month daily average!
There were no significant news releases or other significant events that could be detected.
Provectus develops therapies designed to target and destroy breast cancer, liver cancer, and metastatic melanoma while eliminating side effects.
The company has a tiny market cap of only $86 million. It has $7 million in cash and about $360,000 in debt according to the latest Yahoo! financial data. The company has not registered any significant revenues from operations over the last couple of years.
Shares of Provectus closed at $1.90 on Monday, 12% below the 52-week high of $2.16.
Provectus has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
BioHealthInvestor.com
Shares of Provectus Pharmaceuticals (PVCT.OB) gained more than 15% on Monday as volume was more than six times the 3 month daily average!
There were no significant news releases or other significant events that could be detected.
Provectus develops therapies designed to target and destroy breast cancer, liver cancer, and metastatic melanoma while eliminating side effects.
The company has a tiny market cap of only $86 million. It has $7 million in cash and about $360,000 in debt according to the latest Yahoo! financial data. The company has not registered any significant revenues from operations over the last couple of years.
Shares of Provectus closed at $1.90 on Monday, 12% below the 52-week high of $2.16.
Provectus has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Trader X
- 360 Digest
- Millionaire Now! by Larry Nusbaum
- Alpha Trends
- Jon Aquino's Mental Garden
- The Boston Condo Blog
Examples
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Wed Oct 01, 2008 08:38AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
<< My Home | TheMoneyBlogs Home